OrbiMed Genesis GP LLC's Net Worth

$620 Million

Who is OrbiMed Genesis GP LLC?

OrbiMed Genesis GP LLC has an estimated net worth of $620 Million. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., Keros Therapeutics, Inc., PMV Pharmaceuticals, Inc., Theseus Pharmaceuticals, Inc., Janux Therapeutics, Inc., Edgewise Therapeutics, Inc., Kinnate Biopharma Inc., Ikena Oncology, Inc., Sierra Oncology, Inc., Galecto, Inc., Decibel Therapeutics, Inc., Compass Therapeutics, Inc., Terns Pharmaceuticals, Inc., Enliven Therapeutics, Inc., Disc Medicine, Inc., scPharmaceuticals Inc., Pandion Therapeutics Holdco LLC, ALPINE IMMUNE SCIENCES, INC., and LogicBio Therapeutics, Inc..

SEC CIK

OrbiMed Genesis GP LLC's CIK is 0001808744

Past Insider Trading and Trends

2022 was OrbiMed Genesis GP LLC's most active year for acquiring shares with 36 total transactions. OrbiMed Genesis GP LLC's most active month to acquire stocks was the month of April. 2023 was OrbiMed Genesis GP LLC's most active year for disposing of shares, totalling 49 transactions. OrbiMed Genesis GP LLC's most active month to dispose stocks was the month of March. 2021 saw OrbiMed Genesis GP LLC paying a total of $102,548,267.30 for 59,817,218 shares, this is the most they've acquired in one year. In 2022 OrbiMed Genesis GP LLC cashed out on 4,682,322 shares for a total of $119,872,996.08, their largest year based on trade value.